MEDISTIM ASA (MEDI.OL) Stock Fundamental Analysis

Europe • Euronext Oslo • OSL:MEDI • NO0010159684

218 NOK
-5 (-2.24%)
Last: Feb 5, 2026, 02:56 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to MEDI. MEDI was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making MEDI a very profitable company, without any liquidiy or solvency issues. MEDI is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes MEDI very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year MEDI was profitable.
  • MEDI had a positive operating cash flow in the past year.
  • MEDI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MEDI had a positive operating cash flow.
MEDI.OL Yearly Net Income VS EBIT VS OCF VS FCFMEDI.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

  • The Return On Assets of MEDI (24.76%) is better than 98.53% of its industry peers.
  • With an excellent Return On Equity value of 34.02%, MEDI belongs to the best of the industry, outperforming 98.53% of the companies in the same industry.
  • The Return On Invested Capital of MEDI (30.97%) is better than 98.53% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MEDI is significantly above the industry average of 9.62%.
  • The 3 year average ROIC (24.89%) for MEDI is below the current ROIC(30.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 24.76%
ROE 34.02%
ROIC 30.97%
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
MEDI.OL Yearly ROA, ROE, ROICMEDI.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • MEDI has a Profit Margin of 21.30%. This is amongst the best in the industry. MEDI outperforms 91.18% of its industry peers.
  • MEDI's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 26.88%, MEDI belongs to the best of the industry, outperforming 92.65% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MEDI has remained more or less at the same level.
  • The Gross Margin of MEDI (81.21%) is better than 94.12% of its industry peers.
  • In the last couple of years the Gross Margin of MEDI has remained more or less at the same level.
Industry RankSector Rank
OM 26.88%
PM (TTM) 21.3%
GM 81.21%
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
MEDI.OL Yearly Profit, Operating, Gross MarginsMEDI.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MEDI is creating value.
  • MEDI has about the same amout of shares outstanding than it did 1 year ago.
  • MEDI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MEDI is higher compared to a year ago.
MEDI.OL Yearly Shares OutstandingMEDI.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MEDI.OL Yearly Total Debt VS Total AssetsMEDI.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • MEDI has a debt to FCF ratio of 0.11. This is a very positive value and a sign of high solvency as it would only need 0.11 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.11, MEDI belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
  • MEDI has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.05, MEDI belongs to the top of the industry, outperforming 89.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.11
Altman-Z N/A
ROIC/WACC3.63
WACC8.54%
MEDI.OL Yearly LT Debt VS Equity VS FCFMEDI.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.33 indicates that MEDI has no problem at all paying its short term obligations.
  • MEDI's Current ratio of 3.33 is amongst the best of the industry. MEDI outperforms 88.24% of its industry peers.
  • MEDI has a Quick Ratio of 2.03. This indicates that MEDI is financially healthy and has no problem in meeting its short term obligations.
  • MEDI's Quick ratio of 2.03 is amongst the best of the industry. MEDI outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 2.03
MEDI.OL Yearly Current Assets VS Current LiabilitesMEDI.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.36% over the past year.
  • Measured over the past 5 years, MEDI shows a small growth in Earnings Per Share. The EPS has been growing by 7.96% on average per year.
  • MEDI shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.21%.
  • MEDI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.12% yearly.
EPS 1Y (TTM)40.36%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%48.5%
Revenue 1Y (TTM)22.21%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%25.68%

3.2 Future

  • MEDI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.78% yearly.
  • Based on estimates for the next years, MEDI will show a quite strong growth in Revenue. The Revenue will grow by 11.00% on average per year.
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MEDI.OL Yearly Revenue VS EstimatesMEDI.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
MEDI.OL Yearly EPS VS EstimatesMEDI.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.98 indicates a quite expensive valuation of MEDI.
  • The rest of the industry has a similar Price/Earnings ratio as MEDI.
  • When comparing the Price/Earnings ratio of MEDI to the average of the S&P500 Index (28.25), we can say MEDI is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 27.90, the valuation of MEDI can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MEDI.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. MEDI is around the same levels.
Industry RankSector Rank
PE 27.98
Fwd PE 27.9
MEDI.OL Price Earnings VS Forward Price EarningsMEDI.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MEDI is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MEDI indicates a somewhat cheap valuation: MEDI is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.93
EV/EBITDA 19.36
MEDI.OL Per share dataMEDI.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • MEDI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)3.52
EPS Next 2Y13.46%
EPS Next 3Y11.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.64%, MEDI has a reasonable but not impressive dividend return.
  • MEDI's Dividend Yield is rather good when compared to the industry average which is at 1.03. MEDI pays more dividend than 83.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, MEDI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

  • The dividend of MEDI is nicely growing with an annual growth rate of 14.87%!
Dividend Growth(5Y)14.87%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • The dividend of MEDI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DPN/A
EPS Next 2Y13.46%
EPS Next 3Y11.78%
MEDI.OL Yearly Income VS Free CF VS DividendMEDI.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDISTIM ASA

OSL:MEDI (2/5/2026, 2:56:45 PM)

218

-5 (-2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-24
Earnings (Next)02-26
Inst Owners61.93%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap4.00B
Revenue(TTM)668.61M
Net Income(TTM)142.42M
Analysts85.71
Price Target265.2 (21.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend4.5
Dividend Growth(5Y)14.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.98
Fwd PE 27.9
P/S 5.98
P/FCF 20.93
P/OCF 20.93
P/B 9.55
P/tB 11.51
EV/EBITDA 19.36
EPS(TTM)7.79
EY3.57%
EPS(NY)7.81
Fwd EY3.58%
FCF(TTM)10.42
FCFY4.78%
OCF(TTM)10.42
OCFY4.78%
SpS36.46
BVpS22.82
TBVpS18.94
PEG (NY)1.65
PEG (5Y)3.52
Graham Number63.25
Profitability
Industry RankSector Rank
ROA 24.76%
ROE 34.02%
ROCE 40.19%
ROIC 30.97%
ROICexc 47.84%
ROICexgc 63.44%
OM 26.88%
PM (TTM) 21.3%
GM 81.21%
FCFM 28.57%
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
ROICexc(3y)39.99%
ROICexc(5y)39.99%
ROICexgc(3y)48.52%
ROICexgc(5y)48.01%
ROCE(3y)32.29%
ROCE(5y)33.19%
ROICexgc growth 3Y-6.52%
ROICexgc growth 5Y0.36%
ROICexc growth 3Y-8.47%
ROICexc growth 5Y0.04%
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
F-Score6
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.11
Debt/EBITDA 0.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 93.53%
Profit Quality 134.12%
Current Ratio 3.33
Quick Ratio 2.03
Altman-Z N/A
F-Score6
WACC8.54%
ROIC/WACC3.63
Cap/Depr(3y)105.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.78%
Cap/Sales(5y)N/A
Profit Quality(3y)91.83%
Profit Quality(5y)103.03%
High Growth Momentum
Growth
EPS 1Y (TTM)40.36%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%48.5%
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue 1Y (TTM)22.21%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%25.68%
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A
EBIT growth 1Y40.96%
EBIT growth 3Y4.07%
EBIT growth 5Y7.86%
EBIT Next Year34.29%
EBIT Next 3Y15.73%
EBIT Next 5YN/A
FCF growth 1Y81.09%
FCF growth 3Y-0.65%
FCF growth 5Y12.16%
OCF growth 1Y81.09%
OCF growth 3Y3.75%
OCF growth 5Y12.23%

MEDISTIM ASA / MEDI.OL FAQ

What is the ChartMill fundamental rating of MEDISTIM ASA (MEDI.OL) stock?

ChartMill assigns a fundamental rating of 7 / 10 to MEDI.OL.


What is the valuation status for MEDI stock?

ChartMill assigns a valuation rating of 4 / 10 to MEDISTIM ASA (MEDI.OL). This can be considered as Fairly Valued.


How profitable is MEDISTIM ASA (MEDI.OL) stock?

MEDISTIM ASA (MEDI.OL) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MEDISTIM ASA (MEDI.OL) stock?

The Price/Earnings (PE) ratio for MEDISTIM ASA (MEDI.OL) is 27.98 and the Price/Book (PB) ratio is 9.55.


What is the financial health of MEDISTIM ASA (MEDI.OL) stock?

The financial health rating of MEDISTIM ASA (MEDI.OL) is 7 / 10.